Premenstrual Syndrome (PMS)
Premenstrual syndrome (PMS) is a pattern of cyclical physical, mental, and emotional symptoms in the luteal phase, the part of the cycle after ovulation. The symptoms resolve with or shortly after the start of menstruation. Common features include irritability, mood swings, bloating, sore breasts, fatigue, and trouble focusing. The defining feature is the cyclical pattern. Symptoms appear predictably after ovulation and clear with menstruation.[66]
PMS symptoms range from mild to severe. Premenstrual dysphoric disorder (PMDD) is a separate diagnosis with its own rules, set out in the DSM-5. PMDD requires at least five symptoms in the final week before the period starts. At least one must be a core mood symptom: strong mood swings, irritability or anger, low mood, or anxiety and tension. The symptoms must cause real distress, or get in the way of work, school, or relationships. They must also not be a flare of another condition, such as depression or panic disorder. Daily symptom ratings across at least two cycles confirm the pattern.1 Severe PMS is therefore not the same as PMDD. Day-by-day tracking over at least two cycles tells the two apart. The same tracking tells both apart from conditions that worsen before a period.[66]
PMS remains poorly defined as a clinical condition. Standard care has relied mainly on SSRIs and suppressive hormone drugs. It has not looked into how the luteal phase works.[66] This approach has a consequence. If no one has clearly defined the healthy luteal phase, no one can say exactly when or why it becomes abnormal. Major reproductive medicine bodies agree that no test for luteal dysfunction gives reliably repeatable results. They also agree that a normal hormone threshold for the luteal phase remains an unsolved problem.[45] PMS research rests on that same uncertain foundation. Several theories exist, but none has been established as the cause.
Progesterone is not the cause of PMS. The corpus luteum makes this normal hormone after an ovulatory event. It is essential to normal luteal function.[44] Framing progesterone as the problem inverts the evidence. What is known about the luteal phase supports more likely drivers. One is an abnormal decline in progesterone, estrogen, or both as the cycle closes. Others are a relative imbalance between the two hormones and corpus luteum insufficiency.[131] Body-wide contributors include inflammation, poor insulin control, low nutrient levels, and stress. These are candidate mechanisms, not established causes. A controlled trial of vaginal progesterone for PMS did no better than placebo.[67] The research reflects ongoing study rather than a single settled approach.
Premenstrual-type symptoms occur both in cycles with normal ovulation and in cycles with disturbed ovulation. Their presence alone therefore cannot confirm that ovulation occurred.[220] For this reason, the question to study is the quality of the ovulatory cycle, not the symptom pattern. A problem with the ovulatory event can lead to a corpus luteum defect[111] or weak luteal-phase function. Either one disrupts the hormone pattern of the second half of the cycle. Luteal phase defects can occur even after follicle growth that appears normal.[111] In this context, the cyclical pattern of PMS becomes a clinical question for charting and hormone measurement to resolve. It is more than a symptom cluster to suppress.
The cyclical pattern points straight to luteal phase function as the clinical question to investigate. Fertility charting shows the phase of the cycle with a precision that calendar guesses made after the fact cannot match. It lets clinicians match the timing of symptoms to the hormone phase. The peak day and post-peak phase markers on the chart provide the frame of reference. They show when in the cycle the symptoms begin. When PMS symptoms are severe or disabling, evaluation of luteal phase deficiency and thyroid function is a logical starting point.
A history of PMS before pregnancy is associated with a higher risk of depression after birth (postpartum depression). The association follows a dose-response pattern. Women who report frequent premenstrual symptoms carry a clearly higher risk. The association holds independent of any prior history of depression.[248] This predictive link suggests that the two conditions share luteal-phase and hormonal mechanisms across the reproductive lifespan.
Restorative approaches treat the cyclical nature of PMS as a signal worth decoding, rather than a pattern to override. The luteal phase depends on a healthy ovulatory event. The quality of the ovulatory cycle is therefore the first thing to evaluate. The goal is to describe what happens in the second half of the cycle and to address the contributing factors. Suppression of the cycle would only eliminate the signal.
Cited in this entry
- Hofmeister S, Bodden S. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician. 2016;94(3):236-40. https://pubmed.ncbi.nlm.nih.gov/27479626/
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.

